{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"progressive-familial-intrahepatic-cholestasis-type-2","columns":[{"gene":"","key":"population-713346fbac5b28424c13","label":"Cholestasis, progressive familial intrahepatic 2","mondoId":"MONDO:0011156","onsetQualifier":null,"originColumnKey":"MONDO:0011156/OMIM:601847","originalViews":[{"key":"MONDO:0011156/OMIM:601847","label":"Cholestasis, progressive familial intrahepatic 2","scopeLabel":"OMIM:601847","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["15a27f3b0e548e66232aca68dddbc75954c11d9ac886addc1089f490772fa4d7","1e928f3f82810c46bd081207ab65cbd601e649d5b615badad09b1d3cfef39724","33c7ec4b67fcbfbb0be79c36759d1e3b01e747644ec7cad69f9210db563e2b5c","4e5c5e6e8f977f6a5b86ef5b3863817bd9c0aae71cb19d238b79351424e4a2b1","56c05125baf92321316ec1e05a888505c98960e2ee765e891d2b4977ebb413cf","578f209b8de865a22fbc788cab94006643d7ee757122888069d1d74a3b641465","5b905f7863a8f5462e6fd7a0c7793927021a92e342f94ea8e931dac8ea7e7698","6c612a3d27f6b9662bc25c643df725e291df4d2a2311d33a157bb3719c3bbc32","7c2ce41ed957db3452c2a5c1a0840ea0420e94da0516b09e8febb03fb9351138","966a892113705bc6779a1dafec532604a9d363f4e80b606a6223168e94d62c62","d6c1841d0641cbf6256fef32b04d7b419e67589b34384df6058f5be3e8a8a9f1","ddda3355665257b89c6445ee2c1537ae39dda4e5f0579d40fb821a84815cb3e4","e34df76901b0f665016d7d980ca63cbf2d06e85139e4673c5c9a91ac6634276c"],"recordQualifiers":{},"scopeLabel":"OMIM:601847","sourceIds":["OMIM:601847"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-713346fbac5b28424c13"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001394","HP:0002908","HP:0002014","HP:0003155","HP:0001508","HP:0002630","HP:0001402"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":13,"sourceGroups":{"omim":13}},"features":[{"hpoId":"HP:0001394","label":"Cirrhosis","primary":true},{"hpoId":"HP:0002908","label":"Conjugated hyperbilirubinemia","primary":true},{"hpoId":"HP:0002014","label":"Diarrhea","primary":true},{"hpoId":"HP:0003155","label":"Elevated circulating alkaline phosphatase concentration","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0002630","label":"Fat malabsorption","primary":true},{"hpoId":"HP:0001402","label":"Hepatocellular carcinoma","primary":true},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001046","label":"Intermittent jaundice","primary":false},{"hpoId":"HP:0001406","label":"Intrahepatic cholestasis","primary":false},{"hpoId":"HP:0000989","label":"Pruritus","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false}],"ledeHtml":"Progressive familial intrahepatic cholestasis type 2 (PFIC2) is a rare condition that affects the liver. People with this condition generally develop signs and symptoms during infancy, which may include severe itching, jaundice, failure to thrive, portal hypertension (high blood pressure in the vein that provides blood to the liver) and hepatosplenomegaly (enlarged liver and spleen). Affected people also have an increased risk of developing hepatocellular carcinoma (a form of liver cancer). PFIC2 is caused by change in the ABCB11 gene and is inherited in an autosomal recessive manner.","mondoId":"MONDO:0011156","node":{"canonicalSlug":"progressive-familial-intrahepatic-cholestasis-type-2","comparisons":[{"documentSha256":"e8e0b1c538dd18cdf97583213339ee93bf517fbb11a8aa23d37f81c766a7926e","key":"legacy-progressive-familial-intrahepatic-cholestasis-type-2","kind":"legacy","label":"progressive familial intrahepatic cholestasis type 2","memberIds":["MONDO:0011156"],"mondoId":"MONDO:0011156","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/progressive-familial-intrahepatic-cholestasis-type-2.e8e0b1c538dd18cdf97583213339ee93bf517fbb11a8aa23d37f81c766a7926e.json"},{"documentSha256":"c9da0c240dc80fadfe607a3de3c1373cd6497c5a932e9386adc3a40bc29dca35","key":"expanded-benign-recurrent-intrahepatic-cholestasis","kind":"expanded","label":"benign recurrent intrahepatic cholestasis","memberIds":["MONDO:0009469","MONDO:0011156","MONDO:0011559","MONDO:0019008"],"mondoId":"MONDO:0019008","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-c9da0c240dc80fadfe60.c9da0c240dc80fadfe607a3de3c1373cd6497c5a932e9386adc3a40bc29dca35.json"},{"documentSha256":"55bdbc4a8ffa52e34e44e870067597b984575855bf9c7e194b6510c17887e682","key":"expanded-progressive-familial-intrahepatic-cholestasis","kind":"expanded","label":"progressive familial intrahepatic cholestasis","memberIds":["MONDO:0008892","MONDO:0009469","MONDO:0011156","MONDO:0011214","MONDO:0011497","MONDO:0014381","MONDO:0014884","MONDO:0015762","MONDO:0018804","MONDO:0030360","MONDO:0030503","MONDO:0030505","MONDO:0030800","MONDO:0030810","MONDO:0030815","MONDO:0031040","MONDO:0975807"],"mondoId":"MONDO:0015762","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-55bdbc4a8ffa52e34e44.55bdbc4a8ffa52e34e44e870067597b984575855bf9c7e194b6510c17887e682.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Progressive familial intrahepatic cholestasis type 2","originalSourceId":"ORPHA:79304","paragraphs":["Progressive familial intrahepatic cholestasis type 2 (PFIC2) is a rare condition that affects the liver. People with this condition generally develop signs and symptoms during infancy, which may include severe itching, jaundice, failure to thrive, portal hypertension (high blood pressure in the vein that provides blood to the liver) and hepatosplenomegaly (enlarged liver and spleen). Affected people also have an increased risk of developing hepatocellular carcinoma (a form of liver cancer). PFIC2 is caused by change in the ABCB11 gene and is inherited in an autosomal recessive manner."],"rawAttribution":"MONDO:0011156","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:30Z","upstream":"GARD:0001288","url":"https://rarediseases.info.nih.gov/diseases/1288"},"ownColumnKeys":["population-713346fbac5b28424c13"],"publication":"published","relationships":[{"kind":"parent","label":"benign recurrent intrahepatic cholestasis type 2","mondoId":"MONDO:0011559","slug":"benign-recurrent-intrahepatic-cholestasis-type-2"},{"kind":"parent","label":"progressive familial intrahepatic cholestasis","mondoId":"MONDO:0015762","slug":"progressive-familial-intrahepatic-cholestasis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"15a27f3b0e548e66232aca68dddbc75954c11d9ac886addc1089f490772fa4d7","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1e928f3f82810c46bd081207ab65cbd601e649d5b615badad09b1d3cfef39724","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000989","is_excluded":false,"label":"Pruritus","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"33c7ec4b67fcbfbb0be79c36759d1e3b01e747644ec7cad69f9210db563e2b5c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003155","is_excluded":false,"label":"Elevated circulating alkaline phosphatase concentration","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4e5c5e6e8f977f6a5b86ef5b3863817bd9c0aae71cb19d238b79351424e4a2b1","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002630","is_excluded":false,"label":"Fat malabsorption","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"56c05125baf92321316ec1e05a888505c98960e2ee765e891d2b4977ebb413cf","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"578f209b8de865a22fbc788cab94006643d7ee757122888069d1d74a3b641465","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001394","is_excluded":false,"label":"Cirrhosis","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5b905f7863a8f5462e6fd7a0c7793927021a92e342f94ea8e931dac8ea7e7698","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002908","is_excluded":false,"label":"Conjugated hyperbilirubinemia","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6c612a3d27f6b9662bc25c643df725e291df4d2a2311d33a157bb3719c3bbc32","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002014","is_excluded":false,"label":"Diarrhea","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7c2ce41ed957db3452c2a5c1a0840ea0420e94da0516b09e8febb03fb9351138","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001402","is_excluded":false,"label":"Hepatocellular carcinoma","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"966a892113705bc6779a1dafec532604a9d363f4e80b606a6223168e94d62c62","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d6c1841d0641cbf6256fef32b04d7b419e67589b34384df6058f5be3e8a8a9f1","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001406","is_excluded":false,"label":"Intrahepatic cholestasis","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ddda3355665257b89c6445ee2c1537ae39dda4e5f0579d40fb821a84815cb3e4","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e34df76901b0f665016d7d980ca63cbf2d06e85139e4673c5c9a91ac6634276c","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:601847","disease_name":"Cholestasis, progressive familial intrahepatic 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001046","is_excluded":false,"label":"Intermittent jaundice","onset_id":null,"reference":"OMIM:601847","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/1288\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011156\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0001288</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Progressive familial intrahepatic cholestasis type 2 (PFIC2) is a rare condition that affects the liver. People with this condition generally develop signs and symptoms during infancy, which may include severe itching, jaundice, failure to thrive, portal hypertension (high blood pressure in the vein that provides blood to the liver) and hepatosplenomegaly (enlarged liver and spleen). Affected people also have an increased risk of developing hepatocellular carcinoma (a form of liver cancer). PFIC2 is caused by change in the ABCB11 gene and is inherited in an autosomal recessive manner.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/1288\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"progressive-familial-intrahepatic-cholestasis-type-2","sourceDocuments":[{"name":"GARD: Progressive familial intrahepatic cholestasis type 2","reviewed":null,"source_release":"2026-10-25T03:38:30Z","url":"https://rarediseases.info.nih.gov/diseases/1288"},{"name":"MONDO: progressive familial intrahepatic cholestasis type 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011156"}],"sourceNote":"","synonyms":["ABCB11 progressive familial intrahepatic cholestasis","BSEP deficiency","cholestasis, progressive familial intrahepatic 2","cholestasis, progressive familial intrahepatic, 2","cholestasis, progressive familial intrahepatic, type 2","PFIC2","progressive familial intrahepatic cholestasis caused by mutation in ABCB11","progressive familial intrahepatic cholestasis type 2","severe ABCB11 deficiency"],"takeawayHtml":"","title":"progressive familial intrahepatic cholestasis type 2"},"schemaVersion":1}
